# Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection

Study · id `cardio:ct-nct05430672` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05430672](<https://clinicaltrials.gov/study/NCT05430672>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05430672

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT05430672. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06 (anticipated); primary completion 2023-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT05430672, source copy `cardio:ctgov-nct05430672-2022-06-24`, retrieved 2026-11-18)
- Planned start: 2022-06 (anticipated) (ClinicalTrials.gov record NCT05430672, source copy `cardio:ctgov-nct05430672-2022-06-24`, retrieved 2026-11-18)
- Primary completion: 2023-08 (anticipated) (ClinicalTrials.gov record NCT05430672, source copy `cardio:ctgov-nct05430672-2022-06-24`, retrieved 2026-11-18)
- Completion: 2024-08 (anticipated) (ClinicalTrials.gov record NCT05430672, source copy `cardio:ctgov-nct05430672-2022-06-24`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05430672, source copy `cardio:ctgov-nct05430672-2022-06-24`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05430672-2022-06-24`, retrieved 2026-11-18)

## The registry's words

- Brief title: Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection
- Condition: Aortic Dissection
- Intervention (Device): The Thoracic Aortic Stent Graft System (Zylox-Tonbridge Medical Technology Co., Ltd. )
- Lead sponsor: Zhejiang Zylox Medical Device Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry lists this organization as the lead sponsor: Zhejiang Zylox Medical Device Co., Ltd. (`cardio:org-zhejiang-zylox-medical-device-co-ltd`)

## Provenance

Content hash: 7d95d344e69dc9f602355a3ce19bb9a6ea7e311e4a200cd9fce43d2772697efb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
